Business Context and Reporting Period
Company: Alterity Therapeutics Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: May 2020 (Filed May 22, 2020)
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing discloses a proposed issue of securities (Item 99.1) and is incorporated by reference into Registration Statements on Form S-8 and Form F-3.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notice of a corporate action rather than a financial results report.
Material Changes
Proposed Issue of Securities: The registrant is announcing a proposed issue of securities. Specific details regarding the size, price, or terms of the issuance are not detailed in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, risk factors, or contingencies beyond the disclosure of the proposed securities issue.
Investor Verification Checklist
- Verify the specific terms, size, and pricing of the proposed securities issue referenced in Item 99.1.
- Review the associated Registration Statements (Form S-8 File No. 333-228671; Form F-3 File Nos. 333-220886 and 333-231417) for detailed offering information.
- Confirm the current capital structure and dilution impact of the proposed issuance.